Main Web Site : www.henderson-morley.com

On line shop web site : http://www.herpesexpert.com (Frost and Simpson)

Investor Relations email : investors@henderson-morley.com

Henderson Morley is a drug discovery company

The company has been developed specifically to carry out preliminary sourcing and screening of candidates to combat diseases caused by the herpes family of viruses and certain other DNA viruses

Latest GECR update 15th October 2006

Latest GE&CR update - 15th Oct 2006 :


The news investors have all been waiting for - regarding negotiations with a US dermatological pharmaceutical firm has finally been unveiled. The licence has been granted under an agreement to
Cutanea, a U.S. pharmaceutical company, specialising in the development of dermatology products in the US market.

The licence is for new applications of ICVT for the treatment of dermatological conditions in humans. The agreement and takes the form of an exclusive American, Mexican and Canadian wide licence to bring products to market through a programme of pre-clinical and clinical development of treatments either by Cutanea or through a sub-licence. Under the terms of the Agreement, Henderson Morley will receive up to 6.675 million dollars in development and commercialisation milestone payments up to the point at which the application receives regulatory approval, and will receive royalties on net sales thereafter.

Under its business plan, Henderson Morley has stated its belief that, following clinical development and regulatory licence approval, sales of the product in excess of $1.5 billion could be achieved over the subsequent ten year period. This would give a potential royalty to Henderson Morley in excess of $115 million over this term.

As a drug discovery company, it is imperative that Henderson continues to grant licenses to further develop its technology portfolio. This is the group's third ICVT license agreement. Encouragingly, Cutanea has a great management team with a proven track record of commercialising dermatology products.

Meanwhile, the company has announced that it has been working away on a vaccine against Koi Carp Herpes virus. The group believes it is now ready to start field trials of a
candidate vaccine, in a collaboration with the Internationally renowned Hagerman
Aquaculture Research Institute in Idaho USA. The initial immunogenicity studies should produce results within 6 months, enabling Henderson Morley scientists to optimise the vaccine formulation, with a view to securing a product licence from the veterinary authorities as soon as practicable.

Clearly activity at Henderson Morley has been significant in recent weeks. The licensing announcement is very encouraging, but with the news now out of the way, the shares have eased - a classic case of buy on the rumour, sell on the news. That said, the stock has now pulled back below the recent placing price. With so much going on at the company, further newsflow in the shorter term is far from unlikely.

*Henderson Morley is a corporate client of Bishopsgate Communications which is owned by RSH, the ultimate owner of GE&CR.

Forecasts and a formal recommendation are suspended ahead of the publication of a detailed note next month.

Harry6
I just did , bought in on the news.

HENDERSON MORLEY PLC
(AIM)

STATEMENT ON SHARE PRICE MOVEMENT

The Board of Henderson Morley plc ('Henderson Morley' or 'the Company'), notes
the movement in the Company's share price today.

The Company is able to confirm that it is in a late stage of negotiations with an
AIM-listed life sciences company. This proposed collaboration may lead to the
grant of a licence in respect of another project from Henderson Morley's product
portfolio. A further statement will be made in this respect at the appropriate
time.

The Company will be announcing its interim results for the six months to 31
October 2006 during the course of the next seven days.

--ENDS--

Harry6 i am celebrating the fact that for no reason other than a speculative one i bought 100 thou this am and i am very happy enjoy the ride

I wonder, perhaps Tepnel Life (TED )
2517

Up 103% on the day.

For god's sake Cynic, get out of that Pub/Tea-Dance/Darby & Joan Club and give us some more of your gloom. There's people on here not even millionaires yet!

*quickly scans board for more Cynic posts*

Harry6
Looking good for Monday there was only 20 minutes left of trading after the news came out, I bought in at 2.5. I want to double up or I will join Cynic and we will both be after you. LOL

Driver do you think its too late to top up at these prices?

Beware concerning buying at these levels. HML does have a habit of rising as a result of deals, but when the details come out and it is clear that money is a long way off then it falls like a stone. Look what happened in September last year.

Are you Cynic in disguise,

are you Cynic in disguise...

I agree with haystack.... be careful buying at these levels, only buy if you can sell immediately..... You might be able to make a bit more, just don't leave your computer screen....!

Whooosshhhhh

None of the deals have had up front money. The only money expected short/medium term is for product development. Real revenue is usually years away. It may be a good punt if you want to hang on to them for a few years. Short term the rise may have taken place already.

Haystack
I agree with half of what you are saying but who knows, may be the deals will keep coming?
This will definitely be marked up first thing on Monday and could go back to the 6p days.

A bit of stuff from the other side.


HML float price was 4p - without any licences or partnerships.


The stock is still undervalud on the US deal alone which could net them 100M over a 10 year period.This is achievable according to GECR.

So lets say they achieve 100M over a 10 year period from the US deal.

***10M a year for easy figures.

***Say 6M a year profit on a PE of say 15 = Mckcap of 90M from the US deal alone,dis regarding everything else.

Mckcap at the moment is 14M--3P PER SHARE.

***So at 90M the sp would be 19p per share.Sp if we had another deal similar we are looking at a Mckcap of 150M-200m OR 30P===50P per share.

Driver - interesting stuff, and thanks for that.

I bought some of these early last year and had a good profit in them until the terms of the deal were taken badly by the market back in September.

I was then looking at a loss, but I did some more work on the company and decided it was basically fine and that the fall was overdone, as most market movements seem to be these days, and bought some more to average down.

The price then fell again and I was looking at an even bigger loss, and I'd really put this one on the 2-5 year list, so I was pleasantly surprised when it all took off again today, and I'm now back in profit.

Question is, I'm off to Florence tomorrow until Wednesday - Christmas present from Mrs 6, top gift I thought - and so, do I put on a sell order for Monday morning, or do I run it and hope the price doesn't collapse again?

Incidentally, wasn't this one of ravydavygravy's tips? Anyone know what happened to him, he doesn't seem to post any more?

He was so well informed on the penny shares and he was always happy to share information.

Harry6
I don't think there is a chance of a collapse not before Wednesday anyway there is going to be speculation on how big the deal may be, is there anymore in the pipe line. If in doubt you could always sell half.

Driver thanks for your quantitative opinions, I will be waiting and seeing, hope you are right....

i have made quite a lot of money trading HML in the past, and have been fortunate enough to take my profits before sp collapsed ..... on at least 2/3 occasions!


Chart below may prove some help to you guys ....... watch out for 200 dma at about 3.20 and/or perhaps resistance at 3.80

cynic
Cheers it looks like break out then at 3.8 I think we will see that Mon morning or will we?

Todays Sat Mail 13/01/2007

Drugs minnow HML more than doubled to 305p on confirmation it is in late stage negotiations with an aim listed life science co.about a collaboration which may lead to the grant of a licence in respect of another project from its portfolio.


Could this be the company that HML are in talks with.

http://www.tepnel.com/

Why do you think this could be the company?

I think the price will shoot up in the morning, 3.8p could be the resistance level as Cynic says, but I will hange on and sell when the price starts to dip.... Keep watching thoughs screens on Monday!

It could be one of many companies heres another.

http://www.alltracel.com/


From UK-Analyst

"It was another spectacular day for the shares in Henderson Morley* (HML). The drugs discovery firm, which is a favourite among retail investors, saw its shares rise sharply on heavy volumes. In an announcement released late afternoon, the company said that it was in the late stages of negotiations with an AIM traded life sciences company. Speculation over the identity of the third party was rampant on investment bulletin boards, stirring buyers into action as almost 250 individual share purchases went through in brisk trade. The shares closed the session 1.55p higher at 3.05p as Henderson said a further announcement detailing the particulars would be unveiled within 7 days.".